The global lactation support supplements market size is estimated at USD 710.7 million in 2024, grew to USD 761.16 million in 2025 and is predicted to surpass around USD 1,411.19 million by 2034, expanding at a CAGR of 7.10% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Lactation Support Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Lactation Support Supplements Market Revenue and Volume, by Ingredient Type, 2024-2034
8.1.1 Fenugreek
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Moringa
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Milk thistle
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Fennel
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Oatmeal
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
8.1.6. Others
8.1.6.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Lactation Support Supplements Market Revenue and Volume, by Formulation, 2024-2034
9.1.1. Capsules/Tablets
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Powder
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Liquid
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Lactation Support Supplements Market Revenue and Volume, by Sales Channel, 2024-2034
10.1.1. Online Sales Channel
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Direct Sales Channel
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Pharmacies/Drug Stores
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1.4. Other Offline Channels
10.1.4.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Ingredient Type (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by Sales Channel (2021-2034)
12.1. Nature's Way Products, LLC
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. NutraMarks, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Fairhaven Health, LLC
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Zenwise Health
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. UpSpring LLC
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Oat Mama, LLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Pink Stork
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Motherlove Herbal Company
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Lactation Link LLC
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample